372 related articles for article (PubMed ID: 17300246)
1. A pilot study of the safety and efficacy of picolinic acid gel in the treatment of acne vulgaris.
Heffernan MP; Nelson MM; Anadkat MJ
Br J Dermatol; 2007 Mar; 156(3):548-52. PubMed ID: 17300246
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
3. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
4. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
Lucky AW; Maloney JM; Roberts J; Taylor S; Jones T; Ling M; Garrett S;
J Drugs Dermatol; 2007 Oct; 6(10):981-7. PubMed ID: 17966175
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
[TBL] [Abstract][Full Text] [Related]
6. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; BiaĆecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
7. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
8. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
[TBL] [Abstract][Full Text] [Related]
9. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
10. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
12. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
14. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
15. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
Woolery-Lloyd H; Baumann L; Ikeno H
J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669
[TBL] [Abstract][Full Text] [Related]
16. An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris.
Sardana K; Garg VK
Dermatol Ther; 2010; 23(4):411-8. PubMed ID: 20666829
[TBL] [Abstract][Full Text] [Related]
17. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
Stotland M; Shalita AR; Kissling RF
Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655
[TBL] [Abstract][Full Text] [Related]
18. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
19. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Piette WW; Taylor S; Pariser D; Jarratt M; Sheth P; Wilson D
Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
[TBL] [Abstract][Full Text] [Related]
20. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.
Pazoki-Toroudi H; Nassiri-Kashani M; Tabatabaie H; Ajami M; Habibey R; Shizarpour M; Babakoohi S; Rahshenas M; Firooz A
J Dermatolog Treat; 2010 May; 21(3):212-6. PubMed ID: 20394495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]